VLife Revisiting Shelf Computational research service

Home | Careers | Contact us

Products

Technology

Services

About us

SERVICES NEWS

Sun Pharma
enters into agreement with VLife

PRODUCTS NEWS

Prometheus
360° profiling of a chemical compound

Scientists are confronted with a perennial dilemma of whether it is worthwhile to invest their effort further on a molecule. Similarly, organizations also need significant assurance that it is worthwhile to invest hard earned revenues on a molecule. Late stage failures not only negatively impacts research productivity of the organization but also results in competitive disadvantage due to time gone waste.

If you have compounds that show an early promise but subsequent costs are substantial to move them further into development pipeline, we can help you with a 360° evaluation of their suitability for their intended objective.

This research is carried out by expert VLife scientists who have a sterling track record in discovery of new indications and is enabled by our computational technologies and a multi core parallel processing computational cluster.

Connect with VLife Expert to know more about Prometheus offering and how VLife can create intellectual property for you.

VLife services track record
VLife’s research team has over 300 man years of research experience. VLife Research Services is credited with: • Design and discovery of 3 NCEs • 7 new indication discoveries • Several activity specific research

Prometheus Case studies

• To identify possible adverse events of
customer’s compound

Download here

THE VLIFE SERVICES ADVANTAGE

Our expertise in computational discovery
Success with computation technology requires awareness of not only its strengths but also of the areas where it needs augmentation from other approaches. Being developers of computational technologies, we have proved our expertise by creating IP in 3 NCE classes and 7 new indication discoveries.

Wide diversity of experience
We cater to a variety of sectors and within them, a diversity of areas. e.g. in pharmaceuticals, we have successfully delivered discovery projects in oncology, anti-fungal, diabetes, CNS etc.

State-of-art technology portfolio
Clients benefit from the whole range of VLife's technologies having validated algorithms, published innovations and efficient workflows which are accessible to clients through VLife services.

In-house custom development skills
Generic technologies sometimes are inadequate or inefficient in complex research. For such needs, our in-house team has skills to develop custom technologies ensuring reliable research.

Case studies: VLife services

	Anti-cancer : AKT1 QSAR model development View
	Target identification for existing nutraceutical molecule View
	Role of electron donors in propylene polymerization View